Latest results FY2026 · Prices updated Oct 30, 2026
HQ: TokyoFounded 19413,149 employeesWebsite
A global leader in optical lenses, medical endoscopes, and HDD glass substrates. Characterized by a diversified business development utilizing precision optical technology.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Life Care & Medical | 62% | ¥590.7B | ¥129.5B | 21.9% |
| Information and Communications | 38% | ¥354.8B | ¥192.3B | 54.2% |
Close (Oct 30, 2026)
¥26,210+9.9% (1Y)
HOYA +9.9% over 1Y, 8.3pt below the industry average (57 companies, +18.1%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥947.7B | ¥327.7B | ¥253.1B | ¥1.3T | +9.4% |
| 2025FY | ¥866.0B | — | ¥202.1B | ¥1.2T | +13.6% |
| 2024FY | ¥762.6B | — | ¥181.4B | ¥1.2T | +5.4% |
| 2023FY | ¥723.6B | — | ¥168.6B | ¥1.0T | +9.4% |
| 2022FY | ¥661.5B | — | ¥164.5B | ¥992.8B | +20.7% |
| 2021FY | ¥547.9B | — | ¥125.4B | ¥853.3B | — |
Sources: annual securities reports, earnings releases and other public disclosures (Mar 2025)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
